drugset / Trial / NCT03817034

Multimodal Analgesia for the Reduction of Postoperative Opioid Consumption

NCT03817034

Phase 0 Withdrawn Massachusetts General Hospital
NaSingle-groupOpen-labelTreatment

Summary

The investigators are performing this research study to investigate the efficacy of local infiltration of the surgical wound combining dexmedetomidine, ropivacaine, and ketorolac (treatment group) versus the current standard of care (historical control group), for post-operative pain management.

Timeline

Start
2021-03-11
Primary completion
2021-03-11
Completion
2021-03-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified Other
Subject Ketorolac Other / unclassified Other
Subject Ropivacaine Other / unclassified Other

Indications

No indication recorded.